Medtronic received information via literature regarding the freestyle stentless bioprosthesis in more than 1000 patients. all data were collected from a single center between 1996 and 2005. the study population included 1014 patients (predominantly male; mean age 73 years), all of which were implanted with medtronic freestyle (serial numbers not provided). among all patients adverse events included: reoperations due to structural valve deterioration, paravalvular leak (pvl), pannus formation, unacceptable hemodynamics, incompetent valve due to dilation of sinotubular junction, increased gradient of 30 mmhg, cusp rupture, pericarditis following myocardial infarction (mi), endocarditis, and stiffening of the cusps due to inflammation.Bleeding and neurological events were also reported.Based on the available information, it was unable to determine relatedness to the medtronic product. no additional adverse patient effects were reported.
|